abiraterone has been researched along with Sarcopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attard, G; Bianchini, D; Cassidy, AM; de Bono, JS; Mukherji, D; Olmos, D; Omlin, A; Pezaro, C; Reid, AH; Seed, G; Tunariu, N | 1 |
1 trial(s) available for abiraterone and Sarcopenia
Article | Year |
---|---|
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Androstenols; Antineoplastic Agents, Hormonal; Body Composition; Humans; Male; Maximum Tolerated Dose; Middle Aged; Orchiectomy; Prostatic Neoplasms; Retrospective Studies; Sarcopenia; Treatment Failure | 2013 |